Clinical TrialsSearch results
Number of results: 314
Other
- Phase II study of amrubicin for previously treated advanced non-small cell lung cancer
- Recurrent non-small cell lung cancer
- Gunma University Hospital
- 2009-03-05
Other
- Phase II prospective treatment study for IgG4+MOLPS
- IgG4+MOLPS (IgG4+Multiorgan lymphoproliferative syndrome)
- Department of Hematology and Immunology, Kanazawa Medical University
- 2009-08-10
Other
- Phase II clinical trials of mature B-cell neoplasms in children: A Japanese Cooperative Studies
- mature B-cell non-Hodgkin's lymphoa
- Japanese Pediatric Leukemia/Lymphoma Studu Group(JPLSG)
- 2006-02-05
Other
- Phase II Clinical Trial to test efficacy and safety of relapsed APL (JALSG APL205R study)
- relapsed acute promyelocytic leukemia (APL)
- Japan adult leukemia study group ( JALSG)
- 2005-12-30
Other
- Phase II clinical trial of advanced stage ymphoblastic lymphoma. A Japanese Pediatric Cooperative Study
- Advanced stage lymphoblastic lymphoma of children.
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-07-26
Other
- Phase I/II Study of Docetaxel and S-1 Combination Therapy for Advanced Non-small Cell Lung Cancer
- Advanced Non-small Cell Lung Cancer
- The Tokyo Cooperative Oncology Group
- 2005-11-14
Other
- Phase I Study of gemtuzumab ozogamicin in combination with cytarabinne and idarubicin as induction therapy for relapsed or refractory patients with acute myeloid leukemia.
- Acute Myeloid Leukemia
- Japan Adult Leukemia Study Group
- 2008-05-10
Other
- Phase 2 study of induction and early consolidation therapy for acute lymphoblastic leukemia in children (TCCSG ALL L04-16).
- Acute Lymphoblastic Leukemia
- Tokyo Children's Cancer Study Group
- 2008-10-05
Other
- Phase 2 study of imatinib-combined chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia (JALSG Ph+ALL202)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Other
- Phase 2 study of G-CSF priming chemotherapy for high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17